Gts Securities LLC Alkermes Plc. Transaction History
Gts Securities LLC
- $45.4 Billion
- Q3 2024
A detailed history of Gts Securities LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Gts Securities LLC holds 13,972 shares of ALKS stock, worth $420,138. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,972Holding current value
$420,138% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
363Shares Held
182MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$875 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$570 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$391 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$381 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$276 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.94B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...